Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2006 | 04-2006 | 01-2006 | 10-2005 | 07-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -2,028 | -974 | -333 | N/A |
| Depreciation Amortization | N/A | 34 | 21 | 10 | N/A |
| Accounts receivable | N/A | -182 | -2,011 | -714 | N/A |
| Other Working Capital | N/A | -58 | -2,797 | -1,149 | N/A |
| Other Operating Activity | 0 | 651 | 2,327 | 808 | 0 |
| Operating Cash Flow | $N/A | $-1,584 | $-3,435 | $-1,378 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -49 | -39 | -18 | N/A |
| Investing Cash Flow | $N/A | $-49 | $-39 | $-18 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,814 | 1,416 | 798 | N/A |
| Financing Cash Flow | $N/A | $1,814 | $1,416 | $798 | $N/A |
| Beginning Cash Position | N/A | 14,280 | 14,280 | 14,280 | N/A |
| End Cash Position | N/A | 14,460 | 12,223 | 13,682 | N/A |
| Net Cash Flow | $N/A | $181 | $-2,057 | $-598 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -1,584 | -3,435 | -1,378 | N/A |
| Capital Expenditure | N/A | -49 | -39 | -18 | N/A |
| Free Cash Flow | 0 | -1,633 | -3,473 | -1,396 | 0 |